Vaincre la Mucoviscidose   Report issue

Academic/Hospital Phase 4
Founded: Paris France (1965)

Organization Overview

First Clinical Trial
2001
NCT00333385
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Vaincre la Mucoviscidose

Active Ingredients

Drugs in Phase 4 Trials (1)

ceftazidime (fortaz) (1 trial)

Drugs in Other Trials (1)

oxygen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 4)

Fibrosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2